Good outcome associated with blood-brain barrier disruption and lower blood pressure after endovascular therapy

• Published in: Journal of stroke and cerebrovascular diseases 2023-01, Vol.32 (1), p.106870-106870, Article 106870
• Main Authors: Upadhyaya, Parth, Mehta, Amit, Luby, Marie, Ansari, Saeed, Lynch, John K, Hsia, Amie W, Latour, Lawrence L, Kim, Yongwoo
• Format: Article
• Language: English
• Subjects: Acute stroke; Blood brain barrier disruption; Blood pressure; Blood Pressure - physiology; Blood-Brain Barrier - diagnostic imaging; Brain Ischemia; Endovascular Procedures - adverse effects; Endovascular Procedures - methods; Humans; Hypotension; MRI; Post-thrombectomy; Stroke - diagnostic imaging; Stroke - therapy; Thrombectomy - adverse effects; Thrombectomy - methods; Treatment Outcome
• ISSN: 1052-3057; 1532-8511; 1532-8511
• DOI: 10.1016/j.jstrokecerebrovasdis.2022.106870

To evaluate the association between post-endovascular thrombectomy (EVT) blood-brain barrier (BBB) disruption on MRI or CT and average systolic blood pressure (SBP) with favorable 90-day functional outcome. Observational studies have found elevated SBP associated with worse outcomes post-EVT, while recent randomized trials found no difference in targeted BP reduction. There may be a subgroup of patients who benefit from targeted BP reduction post-EVT. This is a single-center study of 1) anterior large vessel occlusion stroke patients treated with EVT from 2015 to 2021, 2) achieved mTICI grade 2b or 3. Hyperintense acute reperfusion marker (HARM), hemorrhagic transformation (HT), and midline shift at 3 h post-EVT and 24 h imaging were assessed independently by multiple raters. Binary logistic regression models were used to determine the association of post-EVT SBP with outcomes. BBB disruption was defined as HT or HARM on 3h post-EVT imaging. Of 103 patients, those with SBP 100-129 versus SBP 130-160 found no significant difference in favorable 90-day outcome (64% vs. 46%, OR 2.11, 95% CI 0.78-5.76, p=0.143). However, among 71 patients with BBB disruption, a significant difference in favorable outcome of 64% in SBP 100-129 vs. 39% in SBP 130-160 group (OR 5.93, 95% CI 1.50-23.45, p=0.011) was found. There was no difference in symptomatic ICH, 90-day mortality, midline shift (≥5 mm), and hemicraniectomy, between BP or BBB groups. BBB disruption on 3h post-EVT imaging and lower SBP was associated with favorable outcome. This imaging finding may guide targeted BP therapy and suggests need for a randomized control trial.